Endothelial Protein C–Targeting Liposomes Show Enhanced Uptake and Improved Therapeutic Efficacy in Human Retinal Endothelial Cells
Open Access
- 1 April 2018
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 59 (5) , 2119-2132
Abstract
Purpose: To determine whether human retinal endothelial cells (HRECs) express the endothelial cell protein C receptor (EPCR) and to realize its potential as a targeting moiety by developing novel single and dual corticosteroid–loaded functionalized liposomes that exhibit both enhanced uptake by HRECs and superior biologic activity compared to nontargeting liposomes and free drug. Methods: EPCR expression of HRECs was investigated through flow cytometry and Western blot assays. EPCR-targeting liposomes were developed by functionalizing EPCR-specific antibodies onto liposomes, and the uptake of liposomes was assessed with flow cytometry and confocal laser scanning microscopy. The therapeutic potential of EPCR-targeting liposomes was determined by loading them with prednisolone either through bilayer insertion and/or by remote loading into the aqueous core. The carrier efficacy was assessed in two ways through its ability to inhibit secretion of interleukins in cells stimulated with high glucose and angiogenesis in vitro by using an endothelial cell tube formation assay. Results: HRECs express EPCR at a similar level in both human aortic and umbilic vein endothelial cells. The EPCR-targeting liposomes displayed at least a 3-fold higher uptake compared to nontargeting liposomes. This enhanced uptake was translated into superior anti-inflammatory efficacy, as the corticosteroid-loaded EPCR-targeting liposomes significantly reduced the secretion of IL-8 and IL-6 and inhibited the development of cell tube formations in contrast to nontargeting liposomes. Conclusions: We show that HRECs express EPCR and this receptor could be a promising nanomedicine target in ocular diseases where the endothelial barrier of the retina is compromised.Keywords
This publication has 62 references indexed in Scilit:
- Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African childrenBlood, 2013
- IL-1β Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1β AutostimulationPLOS ONE, 2012
- Characterisation of the vitreous proteome in proliferative diabetic retinopathyProteome Science, 2012
- Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with GlucocorticoidsPLOS ONE, 2011
- Glucocorticoid-Mediated Inhibition of Angiogenic Changes in Human Endothelial Cells Is Not Caused by Reductions in Cell Proliferation or MigrationPLOS ONE, 2010
- Dexamethasone Enhances ATP-Induced Inflammatory Responses in Endothelial CellsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic RetinopathyJournal of Diabetes Research, 2007
- Vascular Endothelial Growth Factor Reduced and Connective Tissue Growth Factor Induced by Triamcinolone in ARPE19 Cells under Oxidative StressInvestigative Ophthalmology & Visual Science, 2005
- The Endothelial Cell Protein C Receptor (EPCR) Functions as a Primary Receptor for Protein C Activation on Endothelial Cells in Arteries, Veins, and CapillariesBiochemical and Biophysical Research Communications, 1999
- The IL-8 Production in Endothelial Cells is Stimulated by High GlucoseHormone and Metabolic Research, 1996